Hybridomas (monoclonal and polyclonal antibodies)

Hybridomas are specialized cells created by fusing a specific type of immune cell, typically a B lymphocyte (producing a desired antibody), with a myeloma (cancerous plasma) cell. This fusion combines the ability of B cells to produce antibodies with the myeloma cell's capacity for unlimited growth in culture.